Evidence map›Paper›PMID 31082270›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Will a Low-Dose Option Improve Uptake of Tamoxifen for Breast Cancer Risk Reduction?

Carol J Fabian

Registry-linked trialAbstract readComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05133674 (Therapeutic Dose Monitoring), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05133674 phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

Therapeutic Dose Monitoring (TDM) of Tamoxifen and Its Active Metabolites in Combination With Patient-reported Symptom Scores Among Patients With Breast Cancer Receiving Adjuvant Tamoxifen Treatment

TypeinterventionalSponsorKarolinska University HospitalRan2022 to 2023Enrolled40ConditionsBreast Cancer, Breast Carcinoma, Breast Tumors, Cancer of BreastArmsTamoxifen 20 mg
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Carol J Fabian1 University of Kansas Medical Center, Westwood, KS.
University of Kansas Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsTamoxifenBreastHumansNeoplasm Recurrence, LocalRisk Reduction BehaviorTamoxifen

Identifiers

PMID31082270
OpenAlexW2945458697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.